Volume 25, Number 10—October 2019
CME ACTIVITY - Synopsis
Case Studies and Literature Review of Pneumococcal Septic Arthritis in Adults
|Patient age, y/sex||Antimicrobial drugs, initial intravenous therapy; duration, d||Antimicrobial drugs, change to oral therapy||Surgical intervention||Duration of antimicrobial therapy, d||Clinical outcome|
|90/M||Ceftriaxone and rifampin; 4||Levofloxacin and rifampin||Arthrotomy and replacement of prosthetic joint||42||Recovered, regained baseline joint function|
|93/F||Ceftriaxone and gentamicin; 5||Levofloxacin and clindamycin||Arthrotomy and synovectomy||120||Recovered, regained baseline joint function|
|34/M||Amoxicillin and gentamicin; 4||Levofloxacin and amoxicillin||None||42||Recovered, moderately reduced range of motion|
|68/M||Amoxicillin and gentamicin; 2||NA||None||2||Died 2 d after admission from multiorgan failure related to colchicine overdose|
|75/M||Amoxicillin and gentamicin, then amoxicillin and levofloxacin; 11||Levofloxacin||None||42||Recovered, regained baseline joint function|
|42/F||Vancomycin and gentamicin; 6||Levofloxacin and rifampin||Arthrotomy||42||Recovered, moderately reduced range of motion|
|80/F||Ofloxacin and cloxacillin; 1||Amoxicillin||None||42||Recovered, regained baseline joint function|
|61/F||Amoxicillin and levofloxacin and rifampin; 7||Amoxicillin and rifampin||Arthrotomy||42||Recovered, regained baseline joint function|
|57/F||Amoxicillin and gentamicin; 5||Amoxicillin||None||42||Recovered, moderately reduced range of motion|
|53/F||Ceftriaxone and gentamicin; 15||Levofloxacin||None||84||Recovered, regained baseline joint function|
|69/M||Amoxicillin and gentamicin; ND||ND||ND||ND||Recovered, regained baseline joint function|
|82/F||Cefotaxime and gentamicin; 7||Levofloxacin and rifampin||Arthrotomy||47||Recovered, moderately reduced range of motion|
|57/M||Amoxicillin and gentamicin; 27||Amoxicillin||Arthrotomy and synovectomy||42||Recovered, moderately reduced range of motion|
|82/M||Amoxicillin and gentamicin; 10||Amoxicillin||None||42||Recovered, regained baseline joint function|
*NA, not applicable; ND, no data.
1These authors contributed equally to this article.
Page created: September 12, 2019
Page updated: September 12, 2019
Page reviewed: September 12, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.